您要查找的是不是：
- Cardiogenic shock: a failure in reperfusion. Time for a strategic change? （心源性休克：再灌注失败。改变治疗时间？）
- Cardiogenic shock and sudden death have also been attributed to myocardial bridging . 也曾有人指出心因性休克及猝死与心肌架桥有关。
- We report a case of coronary artery spasm of the non-infarct-related arteries during an acute myocardial infarction with cardiogenic shock. 我们报告一个在急性心肌梗塞并发心因性休克时在非梗塞冠状动脉的痉孪。
- Patients with CHF and cardiogenic shock are not candidates for this type of procedure. 患有充血性心力衰竭和心脏休克的病人不宜进行此种治疗。
- Even when treated, mortality from cardiogenic shock after MI and from septic shock is high (60 to 65%). 即使加以治疗，心肌梗塞后的心源性休克和败血症性休克的死亡率也很高（60-65%25）。
- Objective To treat acute myocardial infarction with cardiogenic shock by emegency PCI. 目的探讨急性心肌梗死合并心源性休克的抢救方法。
- Cardiogenic shock usually follows myocardial infarction when the systolic blood passure falls below 80mmHg. 收缩压降到80毫米汞柱以下时,心肌梗塞往往继发心源性休克。
- "But it increased the risk of cardiogenic shock by 11 cases per 1,000 (P <.00001)," Dr.Collins said. 但是这项治疗却会增加1000位病患中，11位发生心因性休克的风险（P＜.;00001）。
- RBBB pattern in the ECG and cardiogenic shock are significant predictors of in-hospital mortality. 可以提供临床医师在诊断左主冠状动脉急性阻塞患者非常好用的参考依据。
- Methods The clinical data of 42 AMI patients with cardiogenic shock treated by IABP were retrospectively studied. 方法回顾42名接受IABP治疗的AMI心源性休克患者,记录所有患者的转归,对不同死亡原因进行分析。
- Cardiogenic shock was suspected. In addition to Dopamine, Doubter and Nipride treatment, IABP (intra aortic Ballon pump) was inserted on Aug. 22. 除了给予多巴胺,多巴酚丁胺和硝普钠治疗外,r8月22H起置入主动脉弓内球囊反搏治疗。
- Cardiogenic shock was suspected. In addition to Dopamine, Doubter and Nipride treatment, IABP (intra aortic balloon pump) was inserted on Aug. 22. 除了给予多巴胺,多巴酚丁胺和硝普钠治疗外,r8月22H起置入主动脉弓内球囊反搏治疗。
- Methods Twelve patients with cardiogenic shock or low cardiac output syndrome after heart surgery were treated with IABP. 方法对12例心脏手术后并发心源性休克及低心排的患者应用IABP治疗。
- The incidence of acute pulmonary edema, cardiogenic shock, arrhythmia, and mortality were more higher in annormal group. 心功能异常组急性肺水肿、心原性休克、心律失常和病死率均明显高于心功能正常组。
- Diagnosis: Acute massive anterior wall myocardial infarction, Cardiogenic shock, Acute pulmonary edema, Septic shock, Acute renal failure, Essential hypertension, Hyperlipidemia. 诊断:急性广泛前壁心肌梗死心源性休克急性肺水肿感染性休克急性肾功能衰竭原发性高血压高脂血症
- Objective To survey the reasons of failure in the treatment of acute myocardial infarction(AMI) patients with cardiogenic shock by intra-aortic balloon counterpulsation(IABP). 目的探讨主动脉内球囊反搏(IABP)救治急性心肌梗死(AMI)心源性休克失败的原因。
- Type 1 CRS reflects an abrupt worsening of cardiac function (e.g., acute cardiogenic shock or decompensated congestive heart failure) leading to acute kidney injury. 1型CRS表现为心功能急进性恶化（如：急性心源性休克或失代偿充血性心衰）导致的急性肾脏损伤。
- The major reasons of death in order were:cardiogenic shock,ventricular fibrillation,acute left heart failure,multiple organ failure,heart rupture and acute renal failure. 结论冠心病冠状动脉支架置入术死亡主要原因是心源性休克、室颤、急性左心衰等。
- This study compared death and major adverse cardiac events (MACE)(re- infarction,heart failure,revascularization,cardiogenic shock) in 1 year between groups receiving and not receiving large dose meto- prolol. 观察发病1 a内两组死亡率和MACE事件(再发心肌梗死、心源性休克、需住院的心力衰竭、再血管化治疗)发生情况。
- RESULTS Patients reguired ECMO support include: heart transplantation,lung transplatation,non-heart-beating donor,postcardiotomy cardiogenic shock,acute myocarditis and neurosurgery ect. 结果施行ECMO支持的病例包括心脏移植,肺移植,无心跳供体,心脏术后心源性休克,急性心肌炎及神经外科手术等。
